Researchers report that vitamin B12 may help treat Verheij syndrome, a rare genetic disorder associated with growth problems and developmental delays. Two outlets describe study findings suggesting B12 can largely reverse developmental abnormalities in lab models with a genetic mutation tied to the condition.

Business Line frames the work around disrupted RNA splicing and how B12-dependent metabolism might connect to the developmental problems seen in Verheij syndrome. ScienceDaily highlights that the effects are observed in organisms engineered to carry the mutation and notes that similar metabolic changes appear in human patients, which supports the idea that the vitamin could inspire new therapies for rare genetic diseases.

While both outlets agree on the overall direction—B12 showing promising effects and pointing to possible mechanisms—their emphasis differs: one focuses more on the proposed biological pathway involving RNA splicing, while the other stresses the degree of reversal in experimental models and the relevance of related metabolic signatures in people.